ANTIBODIES AGAINST OXIDISED THE COMPLEX LOW DENSITY LIPOPROTEIN-BETA-2-GLYCOPROTEIN-I MAY HAVE A PRO-ATHEROGENIC ROLE IN PRIMARY ANTIPHOSPHOLIPID SYNDROME

被引：0
|
作者：
Ames, P. R. J. [1 ]
Delgado-Alves, J. [2 ]
Lopez, D. [3 ]
Lopez, L. [3 ]
Matsuura, E. [4 ]
Margarita, A. [5 ]
Iannaccone, L. [5 ]
Brancaccio, V. [5 ]
机构：
[1] Leeds Gen Infirm, Acad Dept Rheumatol, Leeds, W Yorkshire, England
[2] Curry Cabral Hosp, Dept Internal Med, Lisbon, Portugal
[3] Corgenix Ltd, Sci & Res, Denver, CO USA
[4] Okayama Sch Med, Dept Biochem, Okayama, Japan
[5] Osped A Cardarelli, Angiohaemostasis Unit, Naples, Italy
来源：
RHEUMATOLOGY | 2004年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：109 / 109
页数：1
相关论文
共 42 条
  • [1] Antiphosholipid Syndrome and Pro-Atherogenic Oxidized Low-Density Lipoprotein/b2-Glycoprotein I Complexes
    Matsuura, E.
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 2009, 301 (01) : 43 - 43
  • [2] Antibodies against β2-glycoprotein I complexed with an oxidised lipoprotein relate to intima thickening of carotid arteries in primary antiphospholipid syndrome
    Ames, P. R. J.
    Alves, J. Delgado
    Lopez, L. R.
    Gentile, F.
    Margarita, A.
    Pizzella, L.
    Batuca, J.
    Scenna, G.
    Brancaccio, V.
    Matsuura, E.
    [J]. CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2006, 13 (01): : 1 - 9
  • [3] Arterial disease in lupus and secondary antiphospholipid syndrome: Association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein
    Romero, FI
    Amengual, O
    Atsumi, T
    Khamashta, MA
    Tinahones, FJ
    Hughes, GRV
    [J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1998, 37 (08): : 883 - 888
  • [4] Antiphospholipid, anti-β2-glycoprotein-I and anti-oxidized-low-density-lipoprotein antibodies in antiphospholipid syndrome
    Cuadrado, MJ
    Tinahones, F
    Camps, MT
    De Ramon, E
    Gómez-Zumaquero, JM
    Mujic, F
    Khamashta, MA
    Hughes, GRV
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 1998, 91 (09) : 619 - 626
  • [5] The Significance of Antibodies against Domain I of Beta-2 Glycoprotein I in Antiphospholipid Syndrome
    Kelchtermans, Hilde
    Chayoua, Walid
    de Laat, Bas
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2018, 44 (05): : 458 - 465
  • [6] Antiphospholipid, anti beta 2-glycoprotein I and antioxidized low density lipoprotein antibodies and the risk of antiphospholipid syndrome related features: Analysis of 125 patients.
    Cuadrado, MJ
    Tinahones, F
    Khamashta, MA
    Camps, MT
    deRamon, E
    GomezZumaquero, JM
    Mujic, F
    Hughes, GRV
    [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 446 - 446
  • [7] ANTIBODIES TO PHOSPHOLIPID-FREE BETA(2)-GLYCOPROTEIN-I IN PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME
    CABRAL, AR
    CABIEDES, J
    ALARCONSEGOVIA, D
    [J]. JOURNAL OF RHEUMATOLOGY, 1995, 22 (10) : 1894 - 1898
  • [8] Antibodies to phosphatidylserine/prothrombin complex in suspected antiphospholipid syndrome in the absence of antibodies to cardiolipin or Beta-2-glycoprotein I
    Sanfelippo, M. J.
    Joshi, A.
    Schwartz, S. L.
    Meister, J. A.
    Goldberg, J. W.
    [J]. LUPUS, 2013, 22 (13) : 1349 - 1352
  • [9] Antibodies against domain I of beta2-glycoprotein I are a better predictor for the antiphospholipid syndrome than antibodies to the total protein
    Hollestelle, M. J.
    Van Schagen, M.
    Kariman, A.
    Pequeriaux, N.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 335 - 335
  • [10] Atherogenic oxidized low-density lipoprotein/β2-glycoprotein I (oxLDL/β2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome
    Matsuura, E.
    Kobayashi, K.
    Hurley, B. L.
    Lopez, L. R.
    [J]. LUPUS, 2006, 15 (07) : 478 - 483
12345